Table 3.
Unadjusted and adjusted models for length of stay for the negative screening test cohort
| Characteristic | Unadjusted | Adjusted | ||||
|---|---|---|---|---|---|---|
| % Change | 95% CI 1 | p-value | % Change | 95% CI 1 | p-value | |
| Time period | <0.001 | 0.2 | ||||
| Pre on-site testing | — | — | — | — | ||
| Post on-site testing | −34% | −48%, −21% | −8% | −21%, 5% | ||
| Age, years | 0% | 0%, 0% | 0.7 | 0% | −1%, 0% | 0.1 |
| Gender, male | 7% | −3%, 18% | 0.2 | 5% | −4%, 14% | 0.3 |
| Race/Ethnicity | 0%, 0% | 0.6 | 0%, 0% | 0.4 | ||
| White Non-Hispanic | — | — | — | — | ||
| Black Hispanic | -23% | −60%, 14% | −22% | −55%, 10% | ||
| Black Non-Hispanic | 8% | −10%, 25% | 7% | −9%, 23% | ||
| Other | 4% | −18%, 27% | 2% | −17%, 22% | ||
| White Hispanic | 3% | −12%, 18% | 5% | −8%, 18% | ||
| Payer | 0%, 0% | 0.021 | 0%, 0% | 0.3 | ||
| Commercial | — | — | — | — | ||
| Government | −1% | −37%, 35% | 16% | −15%, 47% | ||
| Medicaid | 11% | −8%, 30% | 8% | −9%, 25% | ||
| Medicare | 4% | −10%, 18% | −5% | −20%, 10% | ||
| Other | −49% | −83%, −15% | −16% | −46%, 14% | ||
| SOFA | 6% | 4%, 8% | <0.001 | 1% | −1%, 3% | 0.4 |
| Received mechanical ventilation during any hospitalization in the previous year | 97% | 77%, 120% | <0.001 | 0%, 0% | ||
| History of tracheostomy usage | 110% | 72%, 150% | <0.001 | 84% | 49%, 120% | <0.001 |
| Central line usage | 88% | 69%, 110% | <0.001 | 45% | 26%, 64% | <0.001 |
| Urinary catheter usage | 70% | 60%, 80% | <0.001 | 64% | 54%, 75% | <0.001 |
| COVID | 14% | 4%, 25% | 0.008 | 45% | 35%, 56% | <0.001 |
| Disposition | 0%, 0% | <0.001 | 0%, 0% | <0.001 | ||
| Expired | — | — | — | — | ||
| Facility | 19% | 1%, 38% | 53% | 36%, 70% | ||
| Home | −31% | −48%, −13% | 9% | −8%, 26% | ||
| Other | −55% | −96%, −14% | −26% | −64%, 12% | ||
| Elixhauser Comorbidity Index | 6% | 5%, 8% | <0.001 | 7% | 5%, 8% | <0.001 |
| Arrival from skilled nursing facility | −14% | −27%, −1% | 0.036 | −21% | −34%, −8% | 0.002 |